Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study
Description
The COVID-19 pandemic represents an excessive burden on health care systems worldwide and the number of patients who require special care in the clinical setting is often hard to predict. Consequently, there is an unmet need for a reliable biomarker